Clinical Trial Update: Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating ivermectin treatment in persons with onchocerciasis-associated epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Universiteit Antwerpen | Conditions: Epilepsy | Phase 4 | Status: COMPLETED